[Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].

[1]  H. Tseng,et al.  Co‐morbidities in psoriasis: a hospital‐based case‐control study , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  C. Cabezas,et al.  Recomendaciones sobre el estilo de vida , 2012, Atencion primaria.

[3]  José Luis Fernández Sueiro,et al.  Documento SER de consenso sobre el uso de terapias biológicas en la artritis psoriásica , 2011 .

[4]  P. Hernández-Sampelayo,et al.  Contribution of nurses to the quality of care in management of inflammatory bowel disease: a synthesis of the evidence. , 2010, Journal of Crohn's & colitis.

[5]  I. Jialal,et al.  Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. , 2010, Metabolic syndrome and related disorders.

[6]  A. Gottlieb,et al.  Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial , 2010, Current medical research and opinion.

[7]  W. Chung,et al.  Relationships between obesity and the clinical severity of psoriasis in Taiwan , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  A. Menter,et al.  The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. , 2010, Journal of the American Academy of Dermatology.

[9]  G. Milligan,et al.  The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  Andrea B Troxel,et al.  Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. , 2010, European heart journal.

[11]  R. Herings,et al.  Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. , 2010, The Journal of investigative dermatology.

[12]  F. Aubin,et al.  Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  J. Alonso,et al.  [Use and application in clinical practice of the CASPAR criteria]. , 2010, Reumatologia clinica.

[14]  I. Schaefer,et al.  Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. , 2010, Acta dermato-venereologica.

[15]  A. Gaspari,et al.  Psoriasis: can statins play a dual role? , 2010, Dermatology online journal.

[16]  Ahmed Al-Mutairi,et al.  Comorbidities associated with psoriasis: An experience from the Middle East , 2010, The Journal of dermatology.

[17]  M. Weichenthal,et al.  Smoking and Alcohol Intake in Severely Affected Patients with Psoriasis in Germany , 2009, Dermatology.

[18]  A. Gottlieb,et al.  Comorbidities in patients with psoriasis. , 2009, The American journal of medicine.

[19]  Y. Tu,et al.  Prevalence of myocardial infarction in patients with psoriasis in central China , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  P. Helliwell,et al.  The prevalence of psoriatic arthritis in people with psoriasis. , 2009, Arthritis and rheumatism.

[21]  C. Ritchlin,et al.  The diagnosis and treatment of early psoriatic arthritis , 2009, Nature Reviews Rheumatology.

[22]  M. Pompili,et al.  Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. , 2009, Journal of hepatology.

[23]  A. Troxel,et al.  The risk of stroke in patients with psoriasis. , 2009, The Journal of investigative dermatology.

[24]  P. Gisondi,et al.  Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. , 2009, Journal of hepatology.

[25]  Nadia Iftikhar,et al.  Patterns of psoriatic arthritis. , 2009, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[26]  A. Kimball,et al.  The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. , 2009, Journal of the American Academy of Dermatology.

[27]  D. Bajaj,et al.  Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. , 2009, JPMA. The Journal of the Pakistan Medical Association.

[28]  R. Fried,et al.  Depression and Quality of Life in Psoriasis , 2009, Postgraduate medicine.

[29]  K. Reich,et al.  Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[30]  P. Helliwell,et al.  Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. , 2009, Clinical and experimental rheumatology.

[31]  S. Jick,et al.  Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case–control analysis , 2009, The British journal of dermatology.

[32]  K. Reich,et al.  Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque‐type psoriasis , 2009, The British journal of dermatology.

[33]  K. Hemminki,et al.  Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden , 2009, British Journal of Cancer.

[34]  A. Qureshi,et al.  Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. , 2009, Archives of dermatology.

[35]  S. Gabriel,et al.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. , 2009, Arthritis and rheumatism.

[36]  A. Bowcock,et al.  New insights into the pathogenesis and genetics of psoriatic arthritis , 2009, Nature Clinical Practice Rheumatology.

[37]  F. Zhang,et al.  Combined effects of HLA‐Cw6 and cigarette smoking in psoriasis vulgaris: A hospital‐based case–control study in China , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[38]  J. Kere,et al.  IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease , 2009, BMC Medical Genetics.

[39]  S. Chimenti,et al.  Influence and Variation of the Body Mass Index in Patients Treated with Etanercept for Plaque-Type Psoriasis , 2009, International journal of immunopathology and pharmacology.

[40]  P. C. van de Kerkhof,et al.  Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies , 2009, The Journal of dermatological treatment.

[41]  M. Weichenthal,et al.  Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis , 2008, The British journal of dermatology.

[42]  Duk-Hee Kang,et al.  Uric acid and cardiovascular risk. , 2008, The New England journal of medicine.

[43]  S. Targan,et al.  IL23R haplotypes provide a large population attributable risk for Crohn's disease , 2008, Inflammatory bowel diseases.

[44]  M. Portella,et al.  Health‐related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality , 2008, Inflammatory bowel diseases.

[45]  J. M. Vázquez,et al.  Obesidad, síndrome metabólico y diabetes: implicaciones cardiovasculares y actuación terapéutica ☆ , 2008 .

[46]  Stefan Jenisch,et al.  Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. , 2008, The Journal of investigative dermatology.

[47]  Elizabeth J Horn,et al.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. , 2008, Journal of the American Academy of Dermatology.

[48]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. , 2008, Journal of the American Academy of Dermatology.

[49]  S. Eyre,et al.  Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. , 2008, The Journal of investigative dermatology.

[50]  D. Torres,et al.  Diagnosis and therapy of nonalcoholic steatohepatitis. , 2008, Gastroenterology.

[51]  J. Meyerovitch,et al.  Psoriasis and diabetes: a population‐based cross‐sectional study , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[52]  M. Y. Güleç,et al.  Temperament and character profile of patients with psoriasis , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[53]  M. Bala,et al.  Psoriasis: cardiovascular risk factors and other disease comorbidities. , 2008, Journal of drugs in dermatology : JDD.

[54]  G. Favato.  High incidence of smoking habit in psoriatic patients. , 2008, The American journal of medicine.

[55]  S. Chimenti,et al.  Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. , 2008, Pharmacological research.

[56]  A. Kimball,et al.  Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002 , 2008, Dermatology.

[57]  P. Gisondi,et al.  Anti–tumour necrosis factor‐α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[58]  A. Firooz,et al.  The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. , 2008, Archives of Iranian medicine.

[59]  H. Calil,et al.  Inflammatory aspects of depression. , 2008, Inflammation & allergy drug targets.

[60]  Yoshiya Tanaka,et al.  Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. , 2008, Endocrine journal.

[61]  J. Chao,et al.  The costs of Crohn's disease in the United States and other Western countries: a systematic review , 2008, Current medical research and opinion.

[62]  F. Vanaclocha Sebastián,et al.  What Characterizes the Severity of Psoriasis? , 2008, Dermatology.

[63]  J. Meyerovitch,et al.  Association between Psoriasis and the Metabolic Syndrome , 2008, Dermatology.

[64]  L. Naldi,et al.  Medical History, Drug Exposure and the Risk of Psoriasis , 2008, Dermatology.

[65]  D. Gladman,et al.  Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. , 2007, Arthritis and rheumatism.

[66]  Consuelo Huerta,et al.  Incidence and risk factors for psoriasis in the general population. , 2007, Archives of dermatology.

[67]  Hyon K. Choi,et al.  Smoking and the risk of psoriasis in women: Nurses' Health Study II. , 2007, The American journal of medicine.

[68]  R. Robati,et al.  The lipid profile in psoriasis: a controlled study , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[69]  A. Qureshi,et al.  The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. , 2007, Journal of the American Academy of Dermatology.

[70]  G. Vena,et al.  Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[71]  N. Komai,et al.  Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis , 2007, Modern rheumatology.

[72]  Pl de Pablos Velasco,et al.  Epidemiología de la diabetes mellitus , 2007 .

[73]  A. Silman,et al.  Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register , 2007, Arthritis and rheumatism.

[74]  V. Shirinsky,et al.  Efficacy of simvastatin in plaque psoriasis: A pilot study. , 2007, Journal of the American Academy of Dermatology.

[75]  Hyon K. Choi,et al.  Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. , 2007, Archives of internal medicine.

[76]  A. Kotronen,et al.  Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[77]  Renata Cifkova,et al.  Erratum: Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology (Journal of Hypertension (2007) 25, (1105-1187)) , 2007 .

[78]  S. Díaz,et al.  Nuevos criterios de clasificacin en la artritis psorisica , 2007 .

[79]  M. Farshchian,et al.  Serum lipid level in Iranian patients with psoriasis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[80]  S. Piaserico,et al.  Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study , 2007, The British journal of dermatology.

[81]  Frank O. Nestle,et al.  Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis , 2007, Human Genetics.

[82]  D. Ford,et al.  Role of Depression in Quality of Life for Patients with Psoriasis , 2007, Dermatology.

[83]  Anna Viner,et al.  The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. , 2007, Journal of the American Academy of Dermatology.

[84]  L. Nygren,et al.  Marked by Visibility of Psoriasis in Everyday Life , 2007, Qualitative health research.

[85]  Steven J. Schrodi,et al.  A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. , 2007, American journal of human genetics.

[86]  N. Tekin,et al.  Accumulation of Oxidized Low-Density Lipoprotein in Psoriatic Skin and Changes of Plasma Lipid Levels in Psoriatic Patients , 2006, Mediators of inflammation.

[87]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[88]  P. Gisondi,et al.  Plasma homocysteine and folate levels in patients with chronic plaque psoriasis , 2006, The British journal of dermatology.

[89]  E. Laguna,et al.  Influencia de la ansiedad en diversas patologías dermatológicas , 2006 .

[90]  Daniel B. Shin,et al.  Prevalence of cardiovascular risk factors in patients with psoriasis. , 2022, Central European journal of public health.

[91]  H. Cortez‐Pinto,et al.  Hepatic histology in obese patients undergoing bariatric surgery. , 2006, Journal of hepatology.

[92]  Daniel B. Shin,et al.  The risk of lymphoma in patients with psoriasis. , 2006, The Journal of investigative dermatology.

[93]  M. Weichenthal,et al.  Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis , 2006, Archives of Dermatological Research.

[94]  J. R. Banegas,et al.  Prevalencia de dislipemia en las consultas ambulatorias del Sistema Nacional de Salud: estudio HISPALIPID , 2006 .

[95]  C. O'Morain,et al.  Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. , 2006, Gastroenterology.

[96]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[97]  P. Munkholm,et al.  Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.

[98]  R. Duman,et al.  TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.

[99]  D. Moreno-Sánchez.  Epidemiología e historia natural de la hepatopatía grasa no alcohólica primaria , 2006 .

[100]  A. McCullough.  Pathophysiology of nonalcoholic steatohepatitis. , 2006, Journal of clinical gastroenterology.

[101]  F. Carbonnel,et al.  Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data , 2006, Inflammatory bowel diseases.

[102]  A. Burden,et al.  Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin , 2006, The British journal of dermatology.

[103]  S. Chimenti,et al.  An Italian Study on Psoriasis and Depression , 2006, Dermatology.

[104]  A. Gottlieb,et al.  Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial , 2006, The Lancet.

[105]  J. Bos,et al.  Effects of etanercept on quality of life, fatigue, and depression in psoriasis , 2006, The Lancet.

[106]  T. Luger,et al.  Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case–control study , 2006, The British journal of dermatology.

[107]  S. Feldman,et al.  The skinny on psoriasis and obesity. , 2005, Archives of dermatology.

[108]  D. Koh,et al.  The psoriasis disability index in Chinese patients: contribution of clinical and psychological variables , 2005, International journal of dermatology.

[109]  S. Fouéré,et al.  How patients experience psoriasis: results from a European survey , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[110]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[111]  R. Stern,et al.  Epidemiology of psoriatic arthritis in the population of the United States. , 2005, Journal of the American Academy of Dermatology.

[112]  A. Jovelić,et al.  Psoriatic arthritis: a retrospective study of 162 patients. , 2005, Vojnosanitetski pregled.

[113]  Giampiero Girolomoni,et al.  Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. , 2005, European journal of dermatology : EJD.

[114]  C. Turesson,et al.  Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.

[115]  G. Bedogni,et al.  Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study , 2005, Hepatology.

[116]  F. Álvarez,et al.  La mortalidad atribuible al tabaquismo comienza a descender en España , 2005 .

[117]  F. Casellas,et al.  Impairment of Health‐Related Quality of Life in Patients With Inflammatory Bowel Disease: a Spanish Multicenter Study , 2005, Inflammatory bowel diseases.

[118]  M. J. Medrano,et al.  Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales , 2005 .

[119]  A. Sanyal,et al.  Evaluation and management of non-alcoholic steatohepatitis. , 2005, Journal of hepatology.

[120]  N. Shafiq,et al.  Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6) , 2005, International journal of dermatology.

[121]  A. Bowcock,et al.  Psoriasis pathophysiology: current concepts of pathogenesis , 2005, Annals of the rheumatic diseases.

[122]  P. Gaulard,et al.  Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. , 2005, Journal of the American Academy of Dermatology.

[123]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[124]  R. Kirsner,et al.  Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. , 2005, Journal of the American Academy of Dermatology.

[125]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[126]  S. Feldman,et al.  The comorbid state of psoriasis patients in a university dermatology practice , 2005, The Journal of dermatological treatment.

[127]  H. Robertshaw,et al.  Pioglitazone: a promising therapy for psoriasis , 2005, The British journal of dermatology.

[128]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[129]  M. Charlton.  Nonalcoholic fatty liver disease: a review of current understanding and future impact. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[130]  M. Maurici,et al.  Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. , 2004, Annali di igiene : medicina preventiva e di comunita.

[131]  A. Evans,et al.  Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. , 2004, International journal of epidemiology.

[132]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[133]  M. Netea,et al.  Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[134]  J. Kench,et al.  Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.

[135]  F. Rodríguez‐Artalejo,et al.  Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in Spain , 2004, Hypertension.

[136]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[137]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[138]  C. Quirk,et al.  Management of the primary cutaneous lymphomas , 2003, The Australasian journal of dermatology.

[139]  M. Artés,et al.  Burden of illness of Crohn's disease in Spain. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[140]  S. Itoh,et al.  CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and Psoriasis , 2003, Digestive Diseases and Sciences.

[141]  D. Margolis,et al.  Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. , 2003, Archives of dermatology.

[142]  M. Reilly,et al.  The Metabolic Syndrome: More Than the Sum of Its Parts? , 2003, Circulation.

[143]  S. Manzi,et al.  Update on vascular disease in systemic lupus erythematosus , 2003, Current opinion in rheumatology.

[144]  B. Neuschwander‐Tetri,et al.  Corrections: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conference , 2003 .

[145]  E. Mahé,et al.  CD30+ T‐cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab , 2003, The British journal of dermatology.

[146]  E. Martínez-Abundis,et al.  Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. , 2003, Journal of the American Academy of Dermatology.

[147]  A. Alver,et al.  Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[148]  H. Hense,et al.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.

[149]  S. Teutsch,et al.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. , 2003, Diabetes.

[150]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[151]  L. Klareskog,et al.  Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. , 2003, Arthritis and rheumatism.

[152]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[153]  S. Lewington.  Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .

[154]  F. Granath,et al.  Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients , 2003, European Journal of Epidemiology.

[155]  C. Heeschen,et al.  Nicotine Strongly Activates Dendritic Cell–Mediated Adaptive Immunity: Potential Role for Progression of Atherosclerotic Lesions , 2003, Circulation.

[156]  F. Rodríguez‐Artalejo,et al.  A simple estimate of mortality attributable to excess weight in the European Union , 2003, European Journal of Clinical Nutrition.

[157]  G. Ekuklu,et al.  Serum lipid levels in psoriasis. , 2003, Yonsei medical journal.

[158]  H. Stenlund,et al.  Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. , 2002, The Journal of rheumatology.

[159]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[160]  F. Rodríguez‐Artalejo,et al.  Hypertension magnitude and management in the elderly population of Spain , 2002, Journal of hypertension.

[161]  F. Ruschitzka,et al.  Anti–Tumor Necrosis Factor-&agr; Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis , 2002, Circulation.

[162]  Xuejun Zhang,et al.  Frequent use of tobacco and alcohol in Chinese psoriasis patients , 2002, International journal of dermatology.

[163]  G. Loss,et al.  Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? , 2002, Hepatology.

[164]  A. Karaman,et al.  Assessment of depression in subjects with psoriasis vulgaris and lichen planus , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[165]  J. A. Smandía,et al.  Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. , 2002, Journal of the American Academy of Dermatology.

[166]  A. McCullough,et al.  Diabetes mellitus, obesity, and hepatic steatosis. , 2002, Seminars in gastrointestinal disease.

[167]  Berrit C Stroehla,et al.  Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. , 2002, American journal of epidemiology.

[168]  G. Baliva,et al.  Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. , 2002, Archives of dermatology.

[169]  R. Zachariae,et al.  Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. , 2002, Acta dermato-venereologica.

[170]  A. Wahl,et al.  The Bodily Suffering of Living with Severe Psoriasis: In-Depth Interviews with 22 Hospitalized Patients with Psoriasis , 2002, Qualitative health research.

[171]  P. Boffetta,et al.  Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. , 2001, The Journal of investigative dermatology.

[172]  R. Frye,et al.  T-cell immunity in acute coronary syndromes. , 2001, Mayo Clinic proceedings.

[173]  M. B. Camps,et al.  Diagnóstico y seguimiento de la hipertensión arterial en Cataluña. Estudio DISEHTAC , 2001 .

[174]  S. Sans,et al.  Tendencias de la prevalencia, conocimiento, tratamiento y control de la hipertensión arterial entre 1986 y 1996: estudio MONICA-Cataluña , 2001 .

[175]  D. Margolis,et al.  The risk of malignancy associated with psoriasis. , 2001, Archives of dermatology.

[176]  F. Casellas,et al.  Factors affecting health related quality of life of patients with inflammatory bowel disease , 2001, Quality of Life Research.

[177]  J. G. Cerezo,et al.  La homocisteína: ¿El factor de riesgo cardiovascular del próximo milenio? , 2001 .

[178]  A. Losada,et al.  Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population – comparison of the 1997 ADA and the 1985 WHO criteria. The Guía Study. , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[179]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[180]  S. Gabriel,et al.  The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. , 2000, The Journal of rheumatology.

[181]  J. Weinman,et al.  Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1‐year follow‐up , 2000, The British journal of dermatology.

[182]  A. Hannuksela-Svahn,et al.  Psoriasis, its treatment, and cancer in a cohort of Finnish patients. , 2000, The Journal of investigative dermatology.

[183]  L Naldi,et al.  Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. , 1999, Archives of dermatology.

[184]  C. Dromer,et al.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients. , 1999, Revue du rhumatisme.

[185]  D M Reboussin,et al.  Psoriasis causes as much disability as other major medical diseases. , 1999, Journal of the American Academy of Dermatology.

[186]  F. Mahmoud,et al.  Elevated B‐Lymphocyte Levels in Lesional Tissue of Non‐Arthritic Psoriasis , 1999, The Journal of dermatology.

[187]  P. Emery,et al.  Psoriatic arthritis: a unified concept twenty years on. , 1999, Arthritis and rheumatism.

[188]  S. Textor,et al.  Cyclosporin-Induced Hypertension , 1999, Drug safety.

[189]  R. Pettengell,et al.  B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis. , 1999, The British journal of dermatology.

[190]  G. Frentz,et al.  Malignant tumours and psoriasis: a follow‐up study , 1999, The British journal of dermatology.

[191]  R. Krauss,et al.  Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. , 1999, Circulation.

[192]  R. Stern,et al.  Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. , 1998, Archives of dermatology.

[193]  H. Kumbasar,et al.  The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[194]  U. Hipler,et al.  Keratinocyte growth inhibition by streptococcal proteins. , 1998, International journal of molecular medicine.

[195]  R. Still,et al.  ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease. , 1998, Journal of clinical pathology.

[196]  O. Kamel.  Lymphomas during long-term methotrexate therapy. , 1997, Archives of dermatology.

[197]  H. Wigzell,et al.  The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.

[198]  R. Stern,et al.  Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. , 1997, The New England journal of medicine.

[199]  M. Rijn,et al.  Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. , 1996, The American journal of surgical pathology.

[200]  S. Edwards,et al.  Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. , 1995, The Journal of investigative dermatology.

[201]  C. Salvarani,et al.  Prevalence of psoriatic arthritis in Italian psoriatic patients. , 1995, The Journal of rheumatology.

[202]  T Reunala,et al.  Smoking, alcohol and life events related to psoriasis among women , 1994, The British journal of dermatology.

[203]  N. Schork,et al.  Alcohol intake and treatment responsiveness of psoriasis: a prospective study. , 1993, Journal of the American Academy of Dermatology.

[204]  J. F. Fraumeni,et al.  Incidence of cancer among patients with rheumatoid arthritis. , 1993, Journal of the National Cancer Institute.

[205]  E. Falk,et al.  Prevalence of psoriasis in a Norwegian Lapp population. , 1993, Acta dermato-venereologica. Supplementum.

[206]  M. Zanolli,et al.  JOINT COMPLAINTS IN PSORIASIS PATIENTS , 1992, International journal of dermatology.

[207]  J. Koo,et al.  The development of B-cell lymphoma in a patient with psoriasis treated with cyclosporine. , 1992, Journal of the American Academy of Dermatology.

[208]  M. Dougados,et al.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.

[209]  J. Saurat,et al.  Mononuclear cell-bound CD23 is elevated in both atopic dermatitis and psoriasis. , 1991, Journal of dermatological science.

[210]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[211]  T. Reunala,et al.  Alcohol intake: a risk factor for psoriasis in young and middle aged men? , 1990, BMJ.

[212]  R. Stern,et al.  Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. , 1988, The Journal of investigative dermatology.

[213]  D. Gladman,et al.  Psoriatic arthritis (PSA)--an analysis of 220 patients. , 1987, The Quarterly journal of medicine.

[214]  S. Neill,et al.  Alcohol consumption and psoriasis. , 1986, Dermatologica.

[215]  T. Poynard,et al.  Psoriasis, alcohol, and liver disease. , 1985, British medical journal.

[216]  R. Stern.  The epidemiology of joint complaints in patients with psoriasis. , 1985, The Journal of rheumatology.

[217]  R. Stern,et al.  Cutaneous squamous-cell carcinoma in patients treated with PUVA. , 1984, The New England journal of medicine.

[218]  W. Keitel.  [Diagnostic strategy in rheumatology]. , 1976, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[219]  R. Wolf,et al.  Alcohol intake and psoriasis. , 1999, Clinics in dermatology.

[220]  J. Ingram.  Psoriasis: Prevalence, Spontaneous Course, and Genetics , 1963 .

[221]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[222]  Susun Bellew,et al.  Epidemiology and comorbidity of psoriasis in children , 2011 .

[223]  A. Patrizi,et al.  Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy , 2010, Dermatologic therapy.

[224]  L. Naldi.  Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies. , 2010, Clinics in dermatology.

[225]  J. Weinberg.  Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial , 2010 .

[226]  J. Dreiher,et al.  Psoriasis and hypertension: a case-control study. , 2010, Acta dermato-venereologica.

[227]  J. Q. Rosso,et al.  Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality , 2010 .

[228]  M. Ståhle,et al.  Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. , 2009, Acta dermato-venereologica.

[229]  M. Picco.  Psoriasis associated with ulcerative colitis and Crohn's disease , 2009 .

[230]  B. Thiers.  Psoriasis and the risk of incident diabetes mellitus: a population-based study , 2009 .

[231]  S. A. Santiago,et al.  Prevalencia del síndrome metabólico en pacientes con psoriasis grave , 2009 .

[232]  B. Thiers.  Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case–control study , 2009 .

[233]  B. Thiers.  Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis , 2009 .

[234]  F. Birrell,et al.  Psoriatic arthritis - Clinical features and diagnosis , 2008 .

[235]  Setting Brazil.  Establishing a standard definition for child overweight and obesity worldwide: international survey. , 2008 .

[236]  R. Zachariae,et al.  Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. , 2008, Acta dermato-venereologica.

[237]  J. R. Banegas Banegas,et al.  [Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study]. , 2008, Medicina clinica.

[238]  B. Gersh.  Risk of Myocardial Infarction in Patients With Psoriasis , 2007 .

[239]  P. Ferdinandy,et al.  Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. , 2007, American journal of physiology. Heart and circulatory physiology.

[240]  D. Zahger,et al.  Psoriasis and the metabolic syndrome. , 2007, Acta dermato-venereologica.

[241]  J. L. Villa,et al.  Revisión y actualización de la hiperuricemia , 2006 .

[242]  B. Thiers.  Relationship Between Smoking and the Clinical Severity of Psoriasis , 2006 .

[243]  B. Thiers.  Impact of Obesity and Smoking on Psoriasis Presentation and Management , 2006 .

[244]  A. Kimball,et al.  The Psychosocial Burden of Psoriasis , 2005, American journal of clinical dermatology.

[245]  C. Yeung,et al.  Cutaneous Adverse Effects of Lithium , 2004, American journal of clinical dermatology.

[246]  M. Sprangers,et al.  Quality of life in patients with psoriasis: a systematic literature review. , 2004, The journal of investigative dermatology. Symposium proceedings.

[247]  J. Ferlay,et al.  Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.

[248]  A. R. Valenzuela.  Bases de datos en Internet , 2002 .

[249]  F. Palace,et al.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001 .

[250]  C. Main,et al.  The contribution of perceptions of stigmatisation to disability in patients with psoriasis. , 2001, Journal of psychosomatic research.

[251]  G. Farrell,et al.  Etiopathogenesis of Nonalcoholic Steatohepatitis , 2001, Seminars in liver disease.

[252]  Sing Lee,et al.  A control study of the cutaneous side effects of chronic lithium therapy. , 2000, Journal of affective disorders.

[253]  R. Tresserras,et al.  Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. , 1999, Diabetes research and clinical practice.

[254]  J. Levy,et al.  The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus (Short Communication) , 1999, Diabetologia.

[255]  F. Rodríguez‐Artalejo,et al.  [Hypertension-related mortality and arterial pressure in Spain]. , 1999, Medicina clinica.

[256]  S. Wagner,et al.  The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes. , 1996, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[257]  E. Higgins,et al.  Cutaneous disease and alcohol misuse. , 1994, British medical bulletin.

[258]  I. Dobrić,et al.  Frequency of psoriatic arthritis in general population and among the psoriatics in Department of Dermatology. , 1994, Acta dermato-venereologica. Supplementum.

[259]  T. Jerrells,et al.  Recent developments in alcoholism:immunological aspects. , 1993, Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.

[260]  R. Scarpa,et al.  Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. , 1989, Acta dermato-venereologica. Supplementum.

[261]  V. Wright,et al.  Psoriatic arthritis. , 1973, Seminars in arthritis and rheumatism.